Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Florida. Pick another state for the same tag.
Against expectation — 2025
Florida cites F756 more often than its own record predicts
Versus expected share1.41×
1.41 times the share F756 takes of citations nationally.
Share of Florida citations1.11%
Of every deficiency written in Florida in 2025, this is the portion that was F756.
Florida1.11%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Florida surveyors wrote
F756 findings written in Florida, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 20, 2026
Based on interview and record review, the facility failed to ensure that the attending physician documented his rationale when no change was made for a resident's identified medication irregularity for one (Resident #5) of five residents reviewed for unnecessary medications.Findings include:Review of Resident #5's Medication Regimen Reviews from 8/2025 through 7/2026 revealed a pharmacist's recommendation dated 5/22/2026 that read, Omeprazole Oral Tablet Delayed Release: Give 20 mg by mouth one time a day. The recommended duration of therapy is up to 12 weeks unless otherwise clinically indicated. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction